NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 217.35 Mn |
| 10 | NewAmsterdam Pharma | 3.12 Bn | 3.12 Bn | - | 123.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.37 Mn |
| Mar 31, 2026 | 121.72 Mn |
| Dec 31, 2025 | 118.42 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.56 Mn |
| Mar 31, 2025 | 116.12 Mn |
| Dec 31, 2024 | 94.36 Mn |
| Sep 30, 2024 | 94.75 Mn |
| Jun 30, 2024 | 94.71 Mn |
| Mar 31, 2024 | 88.38 Mn |
| Dec 31, 2023 | 82.16 Mn |
| Sep 30, 2023 | 82.47 Mn |
| Jun 30, 2023 | 82.06 Mn |
| Mar 31, 2023 | 81.63 Mn |
| Dec 31, 2022 | 18.97 Mn |
| Dec 31, 2021 | 11.33 Mn |